Kessler C C - OmicsDI

Show results for

Unknown (1493)
Proteomics (129)
Genomics (74)
Transcriptomics (32)
Metabolomics (10)
Genomic (1)

Organisms

Homo sapiens (166)
Mus musculus (31)
Sus scrofa domesticus (8)
Sus scrofa (4)
Drosophila melanogaster (4)
Arabidopsis thaliana (4)
Rattus norvegicus (2)
Triticum aestivum (2)
35510 (1)
Axis axis (1)
Castor fiber (1)
Coelodonta antiquitatis (1)
Equus hydruntinus (1)
Gulo gulo (1)
Hordeum vulgare (1)
Lathyrus oleraceus (1)
Lynx lynx (1)
Manihot esculenta (1)
Martes martes (1)
Megaloceros giganteus (1)
Mylodon darwinii (1)
Plasmodium falciparum 3D7 (1)
Ralstonia pseudosolanacearum GMI1000 (1)
Rattus rattus (1)
Rupicapra rupicapra (1)
Saiga tatarica (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Solanum lycopersicum (1)
Ursus arctos horribilis (1)
Ursus maritimus (1)

Repository

pride (123)
EGA (66)
biostudies-arrayexpress (40)
MetaboLights (9)
MassIVE (5)
dbGaP (1)
GNPS (1)
PanoramaPublic (1)

Tissue

Cell culture (24)
Epithelial cell (9)
Kidney (9)
Brain (8)
Cerebrospinal fluid (7)
Blood (6)
Permanent cell line cell (6)
Bone (4)
Macrophage (4)
Skeletal muscle (4)
Accessory sex gland (3)
Blood cell (3)
Blood platelet (3)
Cell suspension culture (3)
Embryonic stem cell (3)
Leukocyte (3)
Liver (3)
Skin (3)
T cell (3)
B cell (2)
Blood plasma (2)
Fibroblast (2)
HEK-293T cell (2)
Heart (2)
Lung (2)
Lymph node (2)
Plant cell (2)
Platelet (2)
Primary cell (2)
Ewing's sarcoma cell line (1)

Disease

Acute leukemia (4)
Breast cancer (4)
Atypical teratoid rhabdoid tumor (3)
Disease free (3)
Amyotrophic lateral sclerosis type 1 (2)
Brain cancer (2)
Cervical cancer (2)
Duchenne muscular dystrophy (2)
Liver cancer (2)
Neuroblastoma (2)
Parkinson's disease (2)
Acute myeloid leukemia (1)
Adult spinal muscular atrophy (1)
Alzheimer's disease (1)
Amyotrophic lateral sclerosis (1)
Atherosclerosis (1)
Bacterial meningitis (1)
Bone osteosarcoma (1)
Brain glioblastoma multiforme (1)
COVID-19 (1)
Cardiovascular system disease (1)
Cervix carcinoma (1)
Chronic lymphocytic leukemia (1)
Chronic myeloid leukemia (1)
Crohn's disease (1)
Cryptococcal meningitis (1)
End stage renal disease (1)
Endometrial cancer (1)
Female breast cancer (1)
Wounds and Injuries (1)

Technology Type

Mass Spectrometry (123)
Shotgun proteomics (88)
Bottom-up proteomics (24)
Affinity purification coupled with mass spectrometry proteomics (20)
Data-dependent acquisition (10)
Data-independent acquisition (10)
Mass spectrometry (7)
Gel-based experiment (3)
SWATH MS (3)
Mass spectrometry assay (2)
ABI_SOLID, Illumina HiSeq 2000, Illumina 450K, AB 5500xl Genetic Analyzer, AB 5500 Genetic Analyzer, ILLUMINA (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
DiaPASEF (1)
HDMSE (1)
Mass spectrometry imaging (1)
SRM/MRM (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (3)
Orbitrap Fusion Lumos (2)
Q Exactive (2)
Gas Chromatography MS - Positive (GC-MS (Positive)) (2)
MicrOTOF-Q II ESI-Qq-TOF (Bruker) (2)
Illumina Hybridisation Oven (1)
Affymetrix GeneTitan system (1)
Affymetrix GeneChip HT MG-430 PM (1)
Illumina iScan (1)
Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 4000 (1)
LTQ Orbitrap Velos (1)
TimsTOF (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive (1)

Publication Date

2026 (18)
2023 (15)
2021 (15)
2022 (15)
2018 (15)
2015 (14)
2025 (14)
2020 (14)
2019 (13)
2024 (11)
2016 (10)
2014 (7)
2013 (5)
2011 (4)
2012 (3)
2017 (3)
2009 (1)
2008 (1)
2007 (1)

CHEBI ID

CHEBI:116314 (3)
CHEBI:16914 (3)
CHEBI:10642 (2)
CHEBI:137096 (2)
CHEBI:137098 (2)
CHEBI:137124 (2)
CHEBI:137125 (2)
CHEBI:14314 (2)
CHEBI:15978 (2)
CHEBI:16112 (2)
CHEBI:16119 (2)
CHEBI:16335 (2)
CHEBI:16467 (2)
CHEBI:16708 (2)
CHEBI:16811 (2)
CHEBI:16865 (2)
CHEBI:16958 (2)
CHEBI:17151 (2)
CHEBI:17475 (2)
CHEBI:17716 (2)
CHEBI:18186 (2)
CHEBI:18257|CHEBI:18211 (2)
CHEBI:22653 (2)
CHEBI:24266 (2)
CHEBI:25094 (2)
CHEBI:25627 (2)
CHEBI:25633 (2)
CHEBI:26271 (2)
CHEBI:26546 (2)
CHEBI:27266 (2)

Metabolite Name

2-Aminoadipate (260) (2)
2-Isopropylmalate (275) (2)
3-Benzyl-2-methyl-2-tridecanamine (2)
3-Hexenyl salicylic acid (2)
4-Aminobutanoate [GABA] (174) (2)
Adenine (264) (2)
Adenosine (236) (2)
Aminomalonic acid (218) (2)
Beta-Alanine (248) (2)
Choline (2)
Coumarin (2)
Gluconate (333) (2)
Glucose-6-phosphate (387) (2)
Glutamine (155) (2)
Glycerophosphocholine (2)
Heptadecasphinganine (2)
Hexadecylamine (2)
Homoserine (218) (2)
Lactose (361) (2)
Lysine (156) (2)
Lysophosphatidilcholine (2)
Melibiose (361) (2)
Methionine (176) (2)
Myristamide (2)
Octadecadienoic acid (337) (2)
Octadecatrienoic acid (335) (2)
Oleamide (2)
Ornithine|Citrullin (142) (2)
Palmitic amide (2)
Tyrosine (2)

Modification

2x(15)N labeled L-lysine (1)

Study type

Transcription profiling by array (23)
ChIP-seq (6)
RNA-seq of coding RNA (5)
Methylation profiling by array (2)
Methylation profiling by high throughput sequencing (2)
Cell line - High-throughput sequencing (1)
Comparative genomic hybridization by array (1)

Release Date

2022 (203)
2025 (174)
2023 (157)
2021 (155)
2024 (146)
2020 (114)
2019 (92)
2018 (77)
2015 (68)
2016 (63)
2017 (63)
2014 (56)
2013 (30)
2026 (27)
2011 (24)
2012 (23)
2009 (16)
2010 (14)
2008 (9)
2007 (9)
2006 (5)
2004 (2)
2005 (1)
2003 (1)
2001 (1)
1999 (1)
1998 (1)
1996 (1)

Lab affiliation

BioArCh, University of York, United Kingdom (3)
Edinburgh Cancer Research, CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK (3)
TDI Mass Spectrometry Laboratory, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK (3)
Target Discovery Institute, University of Oxford (3)
Analytics Core Facility Essen (ACE), Chemische Biologie, Universität Duisburg-Essen, ZMB, Germany (2)
Discovery Proteomics Facility, University of Oxford (2)
Ludwig-Maximilians-Universität München Genzentrum Laboratory for Functional Genome Analysis Feodor-Lynen-Str. 25 D-81377 München (2)
Research Unit Protein Science, Helmholtz Center Munich, German Research Center for Environmental Health GmbH, Germany (2)
Target Discovery Institute (2)
Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, UK (2)
Target Discovery Institute, NDMRB, University of Oxford (2)
Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK (2)
, Dana-Farber Cancer Institute, Harvard Medical School 360 Longwood Avenue Longwood Center, LC4117 Boston, MA 02215 (1)
-Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht -Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht 3584 CH, Netherlands. -Netherlands Proteomics Center, Padualaan 8, Utrecht 3584 CH, Netherlands. (1)
1 Cambridge Systems Biology Centre, University of Cambridge, Cambridge, UK 2 Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, UK 3 Department of Biochemistry, University of Cambridge, Cambridge, UK (1)
1.MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK 2.CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK (1)
1BHF Centre of Research Excellence, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, UK (1)
Assistant Professor of Medicine Committee on Cancer Biology The University of Chicago (1)
Brain tumor translational targets German Cancer Research Center (DKFZ) Im Neuenheimer Feld 580 69120 Heidelberg Germany (1)
COI-NDM (University of Oxford) (1)
COI-NDM Univesity of Oxford (1)
CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK (1)
Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK (1)
Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK (1)
Caner Saygin, MD Assistant Professor of Medicine Committee on Cancer Biology The University of Chicago (1)
Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester (1)
Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford; Oxford, U.K.; 3MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford; Oxford, U.K. (1)
Chinese Academy of Medical Sciences Oxford Institute (CAMS) - Nuffield Department of Medicine. University of Oxford (1)
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany (1)
Clinical Cooperation Unit Neurooncology B320 German Cancer Research Center Heidelberg (1)

Previous page
1 / 174
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 174
Next page

Sort by:

Relevance

Page size

Detection and Quantification of Novel C-terminal TDP-43 Fragments in ALS-TDP

The pathological hallmark of amyotrophic lateral sclerosis (ALS) is the presence of cytoplasmic inclusions, containing C-terminal fragments of the protein TDP-43. Here, we tested the hypothesis that highly sensitive mass spectrometry with parallel reaction monitoring (MS-PRM) can generate a high-res...

ORGANISM(S): Homo sapiens (Human)

2020-12-17 | PXD022186 | Pride

COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.

Not available

S-EPMC7521940 | biostudies-literature

Conventional and functional assessment of spatial neglect: Clinical practice suggestions.

Not available

S-EPMC6188804 | biostudies-literature

A C-shaped hinge for displacement magnification in MEMS rotational structures.

Not available

S-EPMC10764799 | biostudies-literature

Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP.

Not available

S-EPMC8412074 | biostudies-literature

USP28 deletion and small molecule inhibition destabilises c-Myc and elicits regression of squamous cell lung carcinoma

Lung squamous cell carcinoma (LSCC) is a considerable global health burden, with an incidence of over 600,000 cases per year. Treatment options are limited, and patient 5-year survival rate is less than 5%. The ubiquitin specific protease 28 (USP28) has been implicated in tumorigenesis through its s...

ORGANISM(S): Homo sapiens (Human)

2024-07-30 | PXD023339 | Pride

Abpp Usp28 Lung squamous cell carcinoma (lscc)

Activity-based profiling of deubiquitylating enzymes

This set is a repackaging of PXD031848 (described in https://doi.org/10.3390/ijms23063263: "ABPP-HT*-Deep Meets Fast for Activity-Based Profiling of Deubiquitylating Enzymes Using Advanced DIA Mass Spectrometry Methods") to make each LC-MS/MS experiment individually downloadable and to include TIMSC...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2024-07-24 | MSV000095426 | MassIVE

Reactivity of Atomically Functionalized C-Doped Boron Nitride Nanoribbons and Their Interaction with Organosulfur Compounds.

Not available

S-EPMC6474104 | biostudies-literature

Experimental myositis: an optimised version of C-protein-induced myositis.

Not available

S-EPMC11883622 | biostudies-literature

A tenascin-C mimetic peptide amphiphile nanofiber gel promotes neurite outgrowth and cell migration of neurosphere-derived cells.

Not available

S-EPMC4872638 | biostudies-literature

Previous page
1 / 174
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 174
Next page

Sort by:

Relevance

Page size

1739 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets